Our Products

Afatinib Tablets 30 mg is a targeted therapy used primarily for the treatment of non-small cell lung cancer (NSCLC) with specific mutations in the epidermal growth factor receptor (EGFR), as well as some other types of cancer. Afatinib is a tyrosine kinase inhibitor that works by irreversibly blocking the activity of EGFR and other related receptors involved in cancer cell growth and survival. By inhibiting these pathways, Afatinib helps slow or stop the growth of cancer cells that rely on these signals.

The 30 mg dosage is typically taken once daily, with or without food, as directed by a healthcare provider. Common side effects include diarrhea, rash, mouth sores, fatigue, and changes in liver enzymes. It is important to monitor for gastrointestinal issues and skin reactions, as well as liver function during treatment, to manage side effects and ensure the medication is working effectively.